The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
300 jobs Number of planned job creations
Announcement Date
12 November 2013
Employment effect (start)
Foreseen end date
31 December 2018
Description
German biotechnology company Biotest announced to create at least 300 jobs in Dreieich (Hesse) by extending its production capacities until 2018. This is part of the company’s “Biotest Next Level” investment programme.
Currently, Biotest employs 1,940 people worldwide, 850 of them in Dreieich, where the investment programme shall redouble production capacities.
Sources
12 November 2013: Biotest (press release)
14 November 2013: Offenbacher Post
Citation
Eurofound (2013), Biotest, Business expansion in Germany, factsheet number 76197, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76197.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
